The U.S. Food and Drug Administration (FDA) approved a brand new class of drug for the treatment of insulin-dependent diabetes.? It's an inhaled insulin called "Exubera."? The great news is that many of my diabetic patients have problems with injections for many different reasons.? They may be too thin and not have enough muscle or they may tend to be too squeamish to poke themselves as often as they really need.? Whatever the reason, it's a blessing to have drug companies working to create products that serve a real need.? I am exhuberant about "Exubera."
?
Warning:? All new drugs do not have adequate testing to be absolutely sure that they are safe.? My rule of thumb is simple:
- A drug must be on the market for at least 2-3 years
- Unless no other options are available
- The drug must be low toxicity
- Unless it would result in death to not use it
The other nuances are too subtle and need to be on a patient-by-patient basis.? Nevertheless, I am excited to be part of a movement that will give people the opportunity to experience the benefit of "COMPLETE MEDICINE" that incorporates the latest breakthroughs in modern medical treatment with all the wisdom and power of ancient methods from around the world.? With the "double-whammy" of complete care we can all "breathe easier!"
